Fort Lauderdale – September 08, 2026 -- Lennox International (NYSE: LII) has opened a new National Account Services (NAS) headquarters and training center in Fort Lauderdale, Florida, anchored by a 6,000-square-foot dedicated training space for commercial HVAC technicians.

Providence, R.I. – September 08, 2026 -- EpiVax, Inc. has launched artificial intelligence-driven upgrades to its proprietary ISPRI platform, adding a new JanusMatrix 2.1 model, a tolerance-adjusted immunogenicity score, and an enhanced anti-drug antibody (ADA) prediction model for biotherapeutic developers.

New York – September 08, 2026 -- Datamaran has overhauled its brand identity, positioning and website to reflect its shift from an ESG topic-management tool into an AI-powered governance platform used by legal, risk and executive teams at large enterprises.

New York and London – September 08, 2026 -- Datamaran has rebranded its business, replacing its 12-year sustainability-focused identity with a new visual system and website positioning it as an AI-driven governance platform used by major global corporations.

Thomaston, Maine – September 08, 2026 -- LM Workboats, a division of Lyman-Morse, has been contracted to build a 59-foot aluminum research vessel for the Maryland Department of Natural Resources, targeting year-round operations on the Chesapeake Bay and near-coastal Atlantic waters.

Momence, Illinois – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have settled a patent and trademark lawsuit centered on Aura's NeuroRush® ingredient and FutureCeuticals' whole coffee fruit extract sold as CognatiQ® and NeuroFactor®.

Los Angeles – September 08, 2026 -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) said a peer-reviewed paper in the Journal of Molecular Biology has mapped near-atomic resolution structures of eleven proteins in its Ar-KM bacteriophage, a Pseudomonas aeruginosa-targeting phage tied to the company's late-stage AP-PA02 program.

Momence, Ill. – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have resolved a patent and trademark lawsuit centered on Aura's NeuroRush ingredient, with Aura agreeing to discontinue NeuroRush and transition to FutureCeuticals' CognatiQ whole coffee fruit extract.

Momence, Illinois – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have settled a patent and trademark dispute over Aura's cognitive-health ingredient "NeuroRush," ending the product and replacing it with a new distribution partnership for FutureCeuticals' whole coffee cherry extract, sold as "CognatiQ" and "NeuroFactor."

Norwalk, Conn. – September 08, 2026 -- Bitmine Immersion Technologies (NYSE: BMNR) reported total crypto, cash and moonshot holdings of $15.6 billion as of August 30, 2026, with Ethereum holdings reaching 5,901,112 ETH.